---
title: MedGuard
emoji: π₯
colorFrom: blue
colorTo: green
sdk: gradio
sdk_version: 4.44.1
app_file: app.py
pinned: true
license: mit
short_description: AI Medication Safety with Multi-Agent MCP
tags:
- healthcare
- mcp
- agents
- drug-interactions
- medication-safety
- hackathon
- pharmacogenomics
- clinical-decision-support
- langgraph
- multi-agent
- mcp-in-action-track-enterprise
- building-mcp-track-enterprise
---
# π₯ MedGuard β AI-Powered Medication Safety Platform
## Welcome to our submission for the Hugging Face GenAI Agents & MCP Hackathon!
This project showcases a **production-grade multi-agent system** powered by **LangGraph** and the **Model Context Protocol (MCP)**, designed to analyze medication safety, detect dangerous drug interactions, and provide clinical decision support.
π¬ **[Live Demo Video](https://www.loom.com/share/1b71f296ce10451f8de60a00c33d4d82)** | π **[GitHub Repository](https://github.com/SmartGridsML/mcp1stbirthday_hack)** | π€ **[Claude Desktop Integration](https://github.com/SmartGridsML/mcp1stbirthday_hack/blob/main/MCP_INTEGRATION.md)**
**[X POST](https://x.com/BilalS700/status/1995189560008151331?s=20)**
---
## π Hackathon Tracks
| Track | Target | Status |
|-------|--------|--------|
| **Track 1: Building MCP** | $10,000 | β
10 MCP Tools + 3 Resources |
| **Track 2: Consumer Use** | $10,000 | β
Claude Desktop Integration |
| **Track 3: Agentic Use** | $10,000 | β
Multi-Agent LangGraph System |
| **Blaxel Choice Award** | $2,500 | β
Full Blaxel Platform Integration |
---
## π¨ Why This Matters: The Problem We're Solving
|
### π The Reality of Medication Errors
- **7,000-9,000** Americans die annually from medication errors
- **$42 billion** spent annually on preventable adverse drug events
- **1.5 million** patients harmed yearly by medication errors
- **Polypharmacy** (5+ medications) affects 40% of seniors
- **Drug interactions** cause 125,000+ deaths annually in the US
|
### β
How MedGuard Helps
- **Real-time DDI detection** from 25+ curated interactions
- **Pharmacogenomic analysis** for personalized dosing
- **Beers Criteria** screening for elderly patients
- **Clinical guideline compliance** (AHA/ACC/ADA)
- **Cost optimization** with generic alternatives
|
---
## π Project Overview
MedGuard leverages **5 autonomous AI agents** that collaborate to perform comprehensive medication safety analysis:
| Agent | Role | Key Features |
|-------|------|--------------|
| π **Drug Interaction Agent** | Analyzes DDIs using knowledge graphs | CYP enzyme conflicts, PubMed enhancement, severity scoring |
| π€ **Personalization Agent** | Patient-specific adjustments | Renal/hepatic dosing, pharmacogenomics, Beers Criteria |
| π **Guideline Agent** | Clinical compliance checking | AHA/ACC, ADA, ESC guidelines with evidence levels |
| π° **Cost Agent** | Formulary optimization | Generic substitutions, therapeutic alternatives |
| π **Explanation Agent** | Synthesis and communication | Prioritized recommendations, patient-friendly summaries |
---
## π LangGraph Orchestration Architecture
```
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β MedGuard Multi-Agent Orchestrator β
β β
β START β
β β β
β βΌ β
β βββββββββββββββββββββββββββββββ β
β β Drug Interaction Agent ββββ Entry point (always runs first) β
β β β’ 25+ known DDIs β β
β β β’ CYP enzyme analysis β β
β β β’ ML severity prediction β β
β βββββββββββββ¬ββββββββββββββββββ β
β β β
β βΌ β
β βββββββββββββββββββββββββββββββ β
β β CONDITIONAL ROUTER ββββ Severity-based intelligent routing β
β β Based on risk level β β
β βββββββββββββ¬ββββββββββββββββββ β
β β β
β ββββββββββββΌβββββββββββ β
β β β β β
β βΌ βΌ βΌ β
β "critical" "parallel" "low_risk" β
β β β β β
β βΌ β β β
β ββββββββββ β β β
β β Human β β β β
β β Review β β β β
β β FLAG β β β β
β βββββ¬βββββ β β β
β β ββββββ΄βββββ β β
β β βParallel β β β
β β βExecutionβ β β
β β ββββββ¬βββββ β β
β βΌ βΌ βΌ β
β βββββββββββββββββββββββββββββββ β
β β Personalization Agent β β
β β Guideline Compliance Agent ββββ Run in parallel for efficiency β
β β Cost Optimization Agent β β
β βββββββββββββ¬ββββββββββββββββββ β
β β β
β βΌ β
β βββββββββββββββββββββββββββββββ β
β β Explanation Agent ββββ Final synthesis & prioritization β
β β β’ Safety score (0-100) β β
β β β’ Prioritized actions β β
β β β’ Patient-friendly text β β
β βββββββββββββ¬ββββββββββββββββββ β
β β β
β βΌ β
β END β
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
```
---
## π οΈ MCP Server Integration (10 Tools + 3 Resources)
### MCP Tools
| # | Tool | Description | Parameters |
|---|------|-------------|------------|
| 1 | `analyze_medication_safety` | Full 5-agent pipeline | `patient_id`, `query` |
| 2 | `check_drug_interactions` | DDI detection via Neo4j | `medications[]`, `allergies[]` |
| 3 | `get_personalized_dosing` | Patient-specific dosing | `patient_id`, `medication`, `indication` |
| 4 | `check_guideline_compliance` | Clinical guideline check | `patient_id`, `condition` |
| 5 | `optimize_medication_costs` | Generic alternatives | `medications[]`, `insurance_type` |
| 6 | `get_patient_profile` | Demographics & history | `patient_id` |
| 7 | `search_clinical_guidelines` | BioBERT vector search | `query`, `limit` |
| 8 | `explain_medication_decision` | Patient-friendly text | `analysis`, `reading_level` |
| 9 | `search_pubmed_literature` | PubMed via MCP Search | `query`, `study_types[]` |
| 10 | `search_fda_safety_alerts` | FDA alerts via MCP Search | `drug_name`, `years` |
### MCP Resources
| URI | Description |
|-----|-------------|
| `guidelines://clinical-practice` | Clinical practice guidelines database |
| `database://drug-interactions` | Drug interaction knowledge graph |
| `alerts://fda-safety` | FDA safety communications |
---
## ποΈ Data Sources & Medical Knowledge Bases
Our platform uses **real, authoritative, evidence-based medical data sources**:
### 1. π DrugBank β Drug Interaction Database
- **Purpose**: Curated drug-drug interactions with mechanisms and management
- **Coverage**: 25+ high-risk interaction pairs (expandable to 3,000+)
- **Data**: Severity, mechanism, clinical effect, management strategy, evidence level
- **Usage**: Core DDI detection for all medication safety analysis
### 2. 𧬠Pharmacogenomics Database (PharmGKB)
- **Purpose**: Genetic variants affecting drug metabolism
- **Enzymes Covered**: CYP2D6, CYP2C9, CYP2C19, CYP3A4, CYP1A2
- **Phenotypes**: Poor metabolizer, intermediate, normal, ultrarapid
- **Usage**: Personalized dosing recommendations based on genetic markers
### 3. π΄ AGS Beers Criteria (2023)
- **Purpose**: Potentially inappropriate medications in older adults
- **Coverage**: 30+ medication classes to avoid in elderly
- **Source**: American Geriatrics Society
- **Usage**: Automatic flagging for patients β₯65 years
### 4. π Clinical Practice Guidelines
| Organization | Guidelines Included |
|--------------|---------------------|
| **AHA/ACC** | Heart Failure, AFib, CAD, Hypertension |
| **ADA** | Type 2 Diabetes Standards of Care 2024 |
| **ESC** | European cardiovascular guidelines |
| **KDIGO** | Chronic Kidney Disease 2024 |
### 5. π¬ PubMed/MEDLINE (via MCP Search)
- **Purpose**: Literature search for clinical evidence
- **API**: MCP Search protocol integration
- **Usage**: Enhance recommendations with recent research citations
### 6. β οΈ FDA Safety Communications
- **Purpose**: Drug safety alerts, recalls, black box warnings
- **API**: MCP Search protocol integration
- **Usage**: Real-time safety alert checking
---
## π¦ Technology Stack
| Layer | Technology | Purpose |
|-------|------------|---------|
| **MCP Server** | Python `mcp` SDK | 10 tools, 3 resources, stdio transport |
| **Orchestration** | LangGraph StateGraph | Conditional routing, parallel execution |
| **LLM** | Claude 4 Sonnet / GPT-4o / Gemini 2.0 | Medical analysis, synthesis |
| **Knowledge Graph** | Neo4j | Drug interaction network |
| **Vector Search** | Qdrant + BioBERT | Semantic guideline search |
| **API** | FastAPI | REST endpoints, HIPAA audit logging |
| **Frontend** | Gradio | Interactive demo UI |
| **Databases** | PostgreSQL, Redis | Patient data, session management |
| **Cloud** | Blaxel Platform | Serverless deployment, observability |
---
## π§© Core Components
### π Drug Interaction Agent (`drug_interaction_agent_enhanced.py`)
- **Role**: Primary safety analysis entry point
- **Capabilities**:
- Known interaction database lookup (DrugBank)
- CYP enzyme metabolic conflict detection
- ML-based novel interaction prediction
- PubMed literature enhancement
- Severity classification (minor β moderate β major β critical)
### π€ Personalization Agent (`personalization_agent.py`)
- **Role**: Patient-specific safety adjustments
- **Capabilities**:
- Renal dose adjustments (eGFR-based)
- Hepatic impairment considerations
- Pharmacogenomic analysis (CYP variants)
- Beers Criteria screening (age β₯65)
- Polypharmacy detection (5+/10+ meds)
### π Guideline Compliance Agent (`guideline_compliance_agent.py`)
- **Role**: Evidence-based standard verification
- **Capabilities**:
- Condition-specific therapy checks
- Missing therapy identification
- Guideline citation with evidence levels
- Therapeutic class mapping
### π° Cost Optimization Agent (`cost_optimization_agent.py`)
- **Role**: Formulary and cost efficiency
- **Capabilities**:
- Brand β generic substitution
- Therapeutic class alternatives
- Insurance formulary optimization
- Annual savings calculation
### π Explanation Agent (`explanation_agent.py`)
- **Role**: Clinical synthesis and communication
- **Capabilities**:
- Safety score calculation (0-100)
- Prioritized recommendation list
- Executive summary for clinicians
- Patient-friendly explanations (adjustable reading level)
---
## π§ββοΈ Demo Patients
| ID | Patient | Age | Key Demonstration |
|----|---------|-----|-------------------|
| **P001** | John Smith | 67 | Warfarin + Aspirin (major bleeding risk), CKD Stage 3, CYP2C9*3 |
| **P002** | Maria Garcia | 45 | Sertraline + Tramadol (serotonin syndrome risk) |
| **P003** | Robert Chen | 72 | 8 medications, hyperkalemia risk, HF + COPD + CKD |
| **P004** | Sarah Johnson | 55 | Simvastatin + Amlodipine (CYP3A4 interaction, myopathy risk) |
| **P005** | James Wilson | 78 | 6 Beers Criteria violations, CYP2D6 poor metabolizer |
---
## π Deployment Options
### Option 1: Hugging Face Spaces (This Demo)
```bash
# Already deployed! Just use the Gradio interface above
```
### Option 2: Claude Desktop Integration
```json
{
"mcpServers": {
"healthcare-multi-agent": {
"command": "python",
"args": ["-m", "src.mcp.healthcare_mcp_server"],
"cwd": "/path/to/mcp1stbirthday_hack"
}
}
}
```
### Option 3: Blaxel Platform
```bash
cd my-agent && bl deploy
bl run agent healthcare-multi-agent-system --data '{"inputs": "Analyze patient P001"}'
```
### Option 4: Docker Compose
```bash
docker-compose up -d
# API: http://localhost:8000
# UI: http://localhost:7860
```
---
## π Example Analysis Output
```
π₯ MedGuard Analysis Report
ββββββββββββββββββββββββββββββββββββββββββββββββ
Patient: John Smith (P001) | Age: 67 | Medications: 4
β οΈ SAFETY SCORE: 55/100 (MODERATE RISK)
β οΈ REQUIRES CLINICAL REVIEW
βββ CRITICAL FINDINGS βββ
π΄ MAJOR DRUG INTERACTION: Warfarin + Aspirin
Mechanism: Additive antiplatelet/anticoagulant effects
Effect: Significantly increased bleeding risk (GI, intracranial)
Management: Monitor INR closely, add PPI, use 81mg aspirin only
Evidence: Established (PMID: 27432982)
π RENAL ADJUSTMENT NEEDED: Metformin
eGFR: 58 mL/min (threshold: 30)
Action: Monitor renal function; avoid if eGFR <30
π PHARMACOGENOMIC ALERT: Warfarin + CYP2C9*3
Phenotype: Intermediate metabolizer
Action: May require 20-30% lower warfarin dose
βββ RECOMMENDATIONS βββ
1. [CRITICAL] Review warfarin + aspirin combination
2. [HIGH] Add PPI for gastroprotection
3. [MODERATE] Consider CYP2C9 genotype-guided dosing
4. [LOW] Generic substitution available: Save $285/month
```
---
## π§βπ» Authors
**MedGuard Team** β MCP 1st Birthday Hackathon Submission
- Built with β€οΈ for patient safety
- Leveraging state-of-the-art AI agent orchestration
- Production-ready architecture for healthcare applications
---
## π License
This project is licensed under the **MIT License** β see [LICENSE](LICENSE) for details.
---
## π Acknowledgments
- **Anthropic** for Claude and the MCP protocol
- **Hugging Face** for hosting and the hackathon
- **Blaxel** for serverless AI infrastructure
- **DrugBank**, **PharmGKB**, **AGS**, **AHA/ACC/ADA** for medical knowledge
- The healthcare AI community for inspiration
---
Built for the MCP 1st Birthday Hackathon
Making medication safety accessible through AI agents
π₯ π π€ π¬ π